| Centro De Servicios De Salud Y Bienestar Humano Corp. | |
|
Avenue Jose Gautier Benitez #86 Y #88 Caguas PR 00725-0072 | |
| (787) 448-3302 | |
| Not Available |
| Full Name | Centro De Servicios De Salud Y Bienestar Humano Corp. |
|---|---|
| Speciality | Psychologist |
| Location | Avenue Jose Gautier Benitez, Caguas, Puerto Rico |
| Authorized Official Name and Position | Wilma M Castellanos (OWNER) |
| Authorized Official Contact | 7874483302 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Centro De Servicios De Salud Y Bienestar Humano Corp. Hc 4 Box 47199 Caguas PR 00725 Ph: (787) 448-3302 | Centro De Servicios De Salud Y Bienestar Humano Corp. Avenue Jose Gautier Benitez #86 Y #88 Caguas PR 00725-0072 Ph: (787) 448-3302 |
| NPI Number | 1336745280 |
|---|---|
| Provider Enumeration Date | 12/07/2020 |
| Last Update Date | 02/01/2021 |
| Certification Date | 02/01/2021 |
| Medicare PECOS PAC ID | 0244649937 |
|---|---|
| Medicare Enrollment ID | O20210510002240 |
News Archive
University of Maryland School of Medicine (UMSOM) researchers have identified the most toxic proteins made by SARS-COV-2-the virus that causes COVID-19 - and then used an FDA-approved cancer drug to blunt the viral protein's detrimental effects.
Alder Biopharmaceuticals Inc. today announced that data from two clinical studies of its ALD518 investigational antibody therapeutic will be presented at the Annual Meeting of the American College of Rheumatology in Atlanta.
Tetragenetics Inc., a biotechnology company focused on the development of recombinant vaccines, today reported preclinical study results showing that an investigational nanoparticle-based influenza vaccine protects against a highly pathogenic H5N1 avian influenza strain.
Positive new clinical data were released today on a drug candidate for ulcerative colitis that was first discovered and synthesized at The Scripps Research Institute.
The Ontario Medical Association (OMA) today announced the launch of a wholly-owned, not-for-profit corporation dedicated to improving the quality of healthcare services, the Institute for Quality Management in Healthcare (IQMH).
› Verified 4 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1336745280 | NPI | - | NPPES |
| Provider Name | Salvador E Pabon Cortes |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1255545034 PECOS PAC ID: 2466460597 Enrollment ID: I20060330000425 |
News Archive
University of Maryland School of Medicine (UMSOM) researchers have identified the most toxic proteins made by SARS-COV-2-the virus that causes COVID-19 - and then used an FDA-approved cancer drug to blunt the viral protein's detrimental effects.
Alder Biopharmaceuticals Inc. today announced that data from two clinical studies of its ALD518 investigational antibody therapeutic will be presented at the Annual Meeting of the American College of Rheumatology in Atlanta.
Tetragenetics Inc., a biotechnology company focused on the development of recombinant vaccines, today reported preclinical study results showing that an investigational nanoparticle-based influenza vaccine protects against a highly pathogenic H5N1 avian influenza strain.
Positive new clinical data were released today on a drug candidate for ulcerative colitis that was first discovered and synthesized at The Scripps Research Institute.
The Ontario Medical Association (OMA) today announced the launch of a wholly-owned, not-for-profit corporation dedicated to improving the quality of healthcare services, the Institute for Quality Management in Healthcare (IQMH).
› Verified 4 days ago
| Provider Name | Emerita Encarnacion Mendez Rios |
|---|---|
| Provider Type | Practitioner - Clinical Psychologist |
| Provider Identifiers | NPI Number: 1487064739 PECOS PAC ID: 7719108851 Enrollment ID: I20141015000425 |
News Archive
University of Maryland School of Medicine (UMSOM) researchers have identified the most toxic proteins made by SARS-COV-2-the virus that causes COVID-19 - and then used an FDA-approved cancer drug to blunt the viral protein's detrimental effects.
Alder Biopharmaceuticals Inc. today announced that data from two clinical studies of its ALD518 investigational antibody therapeutic will be presented at the Annual Meeting of the American College of Rheumatology in Atlanta.
Tetragenetics Inc., a biotechnology company focused on the development of recombinant vaccines, today reported preclinical study results showing that an investigational nanoparticle-based influenza vaccine protects against a highly pathogenic H5N1 avian influenza strain.
Positive new clinical data were released today on a drug candidate for ulcerative colitis that was first discovered and synthesized at The Scripps Research Institute.
The Ontario Medical Association (OMA) today announced the launch of a wholly-owned, not-for-profit corporation dedicated to improving the quality of healthcare services, the Institute for Quality Management in Healthcare (IQMH).
› Verified 4 days ago
News Archive
University of Maryland School of Medicine (UMSOM) researchers have identified the most toxic proteins made by SARS-COV-2-the virus that causes COVID-19 - and then used an FDA-approved cancer drug to blunt the viral protein's detrimental effects.
Alder Biopharmaceuticals Inc. today announced that data from two clinical studies of its ALD518 investigational antibody therapeutic will be presented at the Annual Meeting of the American College of Rheumatology in Atlanta.
Tetragenetics Inc., a biotechnology company focused on the development of recombinant vaccines, today reported preclinical study results showing that an investigational nanoparticle-based influenza vaccine protects against a highly pathogenic H5N1 avian influenza strain.
Positive new clinical data were released today on a drug candidate for ulcerative colitis that was first discovered and synthesized at The Scripps Research Institute.
The Ontario Medical Association (OMA) today announced the launch of a wholly-owned, not-for-profit corporation dedicated to improving the quality of healthcare services, the Institute for Quality Management in Healthcare (IQMH).
› Verified 4 days ago
Centro De Servicios Multidisciplinario Equilibrio Inc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: Ave. Munoz Marin, Urb. Villa Criollo, A - 9, Caguas, PR 00725 Phone: 787-746-0100 Fax: 787-746-0100 | |
Associates Psychological Services, Llc. Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 12 Calle Acosta, Esquina Goyco, Suite 202, Caguas, PR 00725 Phone: 787-602-0089 | |
Jmsp Llc Mental Health Clinic Medicare: Medicare Enrolled Practice Location: Hima Plaza I, Ave Luis Munoz Marin Esq Ave Degetau #100, Suite 513, Caguas, PR 00725 Phone: 787-961-0753 | |
Novamind Therapy Group Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 5 Carr 798 Km 0.5, Rio Canas, Caguas, PR 00725 Phone: 787-207-7588 | |
Integrando Centro Evaluativo Y Terapeutico Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: E9 Ave Luis Munoz Marin, Caguas, PR 00725 Phone: 787-653-7310 | |
Psy-q Group, Inc. Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: Ave. Regimiento # 295 De Infanteria Esq. Ricky Seda, Valle Tolima, Caguas, PR 00725 Phone: 787-669-1150 | |
Innovation Mental Health Services Corp Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: Ave Degetau, Urb. Boneville Heights V-18, Caguas, PR 00725 Phone: 787-665-7611 |